Categories: Tech

RiverMeadow Enables Seamless Migration of Workloads to AWS Outposts with Secure, On-Premises Flexibility

LOS GATOS, Calif., July 22, 2025 /PRNewswire/ — RiverMeadow Software, a leading provider of multi-cloud migration and modernization solutions, today announced enhanced support for AWS Outposts, empowering organizations to securely migrate and modernize on-premises workloads AWS-managed infrastructure.

- Advertisement -

As organizations seek to reduce licensing costs and accelerate innovation, many are migrating off legacy platforms such as VMware vSphere. However, strict requirements around data residency, latency, and privacy often prevent migration to Public Cloud. AWS Outposts provides a hybrid cloud solution that allows organizations to run AWS services locally—on-premises—while maintaining seamless integration with the broader AWS ecosystem.

- Advertisement -

RiverMeadow’s Workload Mobility Platform now enables end-to-end migration of workloads to AWS Outposts Racks, offering customers a highly secure and efficient path to modernization without sacrificing compliance or control.

- Advertisement -

“With RiverMeadow’s on prem private deployment, organizations can migrate workloads onto AWS Outposts without any data ever leaving the on-premises environment,” said Jim Jordan, CEO of RiverMeadow. “Our direct source-to-target transfer process ensures the highest levels of data security and efficiency throughout the migration journey.”

- Advertisement -

Key Capabilities & Benefits:

- Advertisement -
  • Private Platform Deployment: RiverMeadow installs directly on AWS Outposts, eliminating the need for data egress and supporting strict regulatory requirements.
  • Direct Data Transfer: Data moves securely from source to target EC2 instances on Outposts—no staging required in AWS Regions.
  • OS Modernization: Upgrade Windows Server and Linux operating systems during migration to reduce technical debt and meet compliance standards.
  • Storage Rightsizing: Optimize AWS Outposts storage usage by dynamically resizing storage during the migration process.

RiverMeadow’s AWS Outposts support is ideal for organizations looking to retain sensitive workloads on-premises while moving away from costly legacy platforms. By combining the power of AWS Outposts with RiverMeadow’s automation and intelligence, customers gain a seamless, secure, and modern migration experience.

- Advertisement -

To learn more about RiverMeadow’s AWS Outposts capabilities or to schedule a demo, visit www.rivermeadow.com.

- Advertisement -

Media Contact:
RiverMeadow Software, Inc.
Email: info@rivermeadow.com 
Web: www.rivermeadow.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/694644/logo_stacked_color_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/rivermeadow-enables-seamless-migration-of-workloads-to-aws-outposts-with-secure-on-premises-flexibility-302510776.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

5 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago